Association of Long-Acting Injectable Antipsychotics and Oral Antipsychotics With Disease Relapse, Health Care Use, and Adverse Events Among People With Schizophrenia

IMPORTANCE: Evidence for improved clinical outcomes with long-acting injectable antipsychotics (LAIAs) vs oral antipsychotics (OAs) is limited in Asian populations and special patient groups, including older people (>65 years), people with substance use, and early initiators of LAIAs. OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Yue, Yan, Vincent K. C., Kang, Wei, Wong, Ian C. K., Castle, David J., Gao, Le, Chui, Celine S. L., Man, Kenneth K. C., Hayes, Joseph F., Chang, Wing Chung, Chan, Esther W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335136/
https://www.ncbi.nlm.nih.gov/pubmed/35900760
http://dx.doi.org/10.1001/jamanetworkopen.2022.24163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335136/
https://www.ncbi.nlm.nih.gov/pubmed/35900760
http://dx.doi.org/10.1001/jamanetworkopen.2022.24163

Ejemplares similares